[HTML][HTML] Sex differences in the outcomes of septal reduction therapies for obstructive hypertrophic cardiomyopathy
J Sreenivasan, MS Khan, R Kaul… - Cardiovascular …, 2021 - jacc.org
J Sreenivasan, MS Khan, R Kaul, D Bandyopadhyay, U Hooda, WS Aronow, HA Cooper…
Cardiovascular Interventions, 2021•jacc.org3. Deharo P, Quilici J, Camoin-Jau L, et al. Benefit of switching dual antiplatelet therapy after
acute coronary syndrome according to on-treatment platelet reactivity: the TOPIC-VASP pre-
specified analysis of the TOPIC randomized study. J Am Coll Cardiol Intv 2017; 10: 2560–
70.
acute coronary syndrome according to on-treatment platelet reactivity: the TOPIC-VASP pre-
specified analysis of the TOPIC randomized study. J Am Coll Cardiol Intv 2017; 10: 2560–
70.
3. Deharo P, Quilici J, Camoin-Jau L, et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome according to on-treatment platelet reactivity: the TOPIC-VASP pre-specified analysis of the TOPIC randomized study. J Am Coll Cardiol Intv 2017; 10: 2560–70.
jacc.org
以上显示的是最相近的搜索结果。 查看全部搜索结果